Rocket Lab's Launch Log Is Full — Wall Street Just Isn't Reading It That Way

Rocket Lab's Electron keeps flying while the stock falls 23% in 30 days. Neutron's Q4 2026 pad goal and a Berenberg Buy rating frame the debate.

Two narratives are running through Rocket Lab's stock right now, and neither one is fabricated. One belongs to a rocket company firing satellites into orbit on a near-weekly basis. The other belongs to a share price that has been sliding for weeks. Both are true at the same time, which is precisely what makes the equity so hard to read.

On Friday, an Electron rocket lifted off from Launch Complex 1 in New Zealand at 15:28 local time, carrying an Earth-observation satellite for an undisclosed customer into a circular orbit at 500 kilometers. It was the company's 16th launch of the year, and another commercial constellation operator is already slated to fly before the month is out. The stock added roughly two percent in pre-market trading and closed Friday at EUR 54.50, up 2.1 percent on the day.

That cadence builds on a mission just nine days earlier. On September 2, the 94th Electron flight delivered StriX, a Japanese Earth-observation satellite operated by Synspective, into a low Earth orbit at 575 kilometers. Synspective has booked 16 additional missions with Rocket Lab through 2030. Watch the operational tempo alone and you see a company keeping rhythm, not one in crisis.

The Other Side of the Tape

The share price tells a harsher story. Over the past 30 days, the stock has shed roughly 23 percent. One source of that pressure appears to have been sector-wide and had little to do with Rocket Lab itself: in early September, NASA awarded its Mars telecommunications network contract to Blue Origin.

Media reports nonetheless tied that decision to weakness in Rocket Lab shares and to sentiment surrounding the Neutron program — even though the award demonstrably was not a Rocket Lab contract. The episode illustrates how jittery the market has become about anything touching the company's next-generation rocket.

That is where the real sticking point lies. Electron is the dependable workhorse, but the growth story hangs on Neutron, the larger launch vehicle meant to catapult Rocket Lab into a different league. In the Q2 update in early August, management said fabrication of the first tank segment was on schedule, with the goal of Neutron arriving on the pad in the fourth quarter of 2026. No concrete launch date was given. That vagueness feeds every sell-off triggered by bad news elsewhere in the sector — news that in reality concerns a competitor.

Contract Wins Pile Up

The order book, meanwhile, keeps expanding. In August, Rocket Lab secured a USD 397 million award from the US Space Force under the SB-AMTI program, covering the development and operation of multiple flatellites aboard the upcoming Neutron rocket. At the end of July, the company had already locked in its largest launch contract to date — a USD 266 million deal for up to 18 suborbital launches, to be carried out largely from its new site in Kodiak, Alaska.

There is structural work on the supply chain as well. In early September, Rocket Lab unveiled IMM Apex, a high-efficiency solar cell for space applications that dispenses with germanium entirely, reducing reliance on scarce critical minerals. With 31.5 percent efficiency and a 40 percent reduction in cell mass, the product is designed to ease supply-chain risk across the space industry. It won't move the stock in a single session, but it is the kind of quiet engineering that signals the company is building more than rockets.

Institutions Buy, an Insider Sells

Big investors appear unbothered by the recent slide. Cathie Wood's ARK Investment Management purchased roughly 681,000 Rocket Lab shares across two trading days ending September 9 — a clear vote of institutional confidence in the growth strategy, with the company now valued at around EUR 36.44 billion.

Moving the other way was CFO Adam C. Spice, who sold 140,157 shares on September 2 at a weighted average price of USD 62.63, a volume of about USD 8.8 million. The transaction stemmed from the exercise of stock options at a strike price of USD 1.09 and was executed under an automated trading plan set up back in June under Rule 10b5-1. In other words, not a spontaneous insider sale but a pre-programmed one — though in weak price phases, some observers still read such filings as an extra warning sign.

Berenberg Sees Room to Run

Early in September, Berenberg initiated coverage with a Buy rating and a price target of USD 83, implying roughly 33 percent upside from the then-price of USD 62.54. The analysts framed Rocket Lab as the only listed pure-play spanning the entire space value chain — launch, satellites, components and spectrum — with a de facto monopoly in the dedicated small-lift segment and an entry into medium-lift via Neutron.

Another structural piece is the multibillion-dollar acquisition of Iridium Communications, announced in June and since cleared by antitrust authorities. Iridium shareholders vote on the transaction on September 24, with closing expected around mid-2027.

What Hangs in the Balance

Rocket Lab has become a case study in how operational substance and share-price action can decouple. On a year-to-date basis, the stock is still up 32 percent, suggesting the longer-term trend hasn't broken — though the past few weeks have clearly taken a toll.

The question for the months ahead is not whether Electron keeps flying reliably. It plainly does. The question is whether Neutron rolls onto the pad on time, and whether the market can muster the patience to separate operational wins from sector-wide nerves until it does.